Skip to content

Drug interactions

Maprotiline + Sunitinib

Severity: Major

Maprotiline and Sunitinib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs can prolong the QT interval, increasing the risk of torsades de pointes when combined. Patients with cardiac disease or electrolyte disturbances are at greatest risk.

What this interaction means in plain words

Maprotiline and Sunitinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Maprotiline belongs to Central Nervous System; Sunitinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Additive QT interval prolongation.

What to do

Obtain baseline and follow-up ECGs and keep potassium and magnesium in the normal range. Consider an antidepressant with less QT effect if feasible.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Maprotiline and Sunitinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Maprotiline with Sunitinib?

MediHelp rates the interaction as major. Maprotiline and Sunitinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both drugs can prolong the QT interval, increasing the risk of torsades de pointes when combined. Patients with cardiac disease or electrolyte disturbances are at greatest risk.

How serious is the interaction between Maprotiline and Sunitinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain baseline and follow-up ECGs and keep potassium and magnesium in the normal range. Consider an antidepressant with less QT effect if feasible.

What other medicines interact with Maprotiline?

MediHelp also lists interactions of Maprotiline with, for example, Arsenic trioxide, Disopyramide, Dofetilide. The full list is on the Maprotiline page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in